OpenApp

Evidence for Healthcare

  • Home
  • What We Do
    • Patient Registries
    • Mapping and Analysis
    • Rare Disease Registries
    • Internal Services
  • Our Work
  • News and Events
  • Company
    • Contact Us
    • Who We Are
    • Our Partners
    • Careers

Patient Registry Owners: Key Highlights of new GDPR – General Data Protection Regulation

November 22, 2016

Data protection is an issue that we regularly discuss with clinicians, clients, patient registry owners and healthcare organisations.

And it’s with data protection in mind that we put this article together. If you are designing a registry, how you collect and store data is so important. And it’s about to get even more important.

Data protection laws around the EU differ significantly from country to country. Current law is based on Directive 95/46/EC (we’ll call this the Directive from now on) which is around since 1985. As it was a Directive, each member state interpreted the law differently so we have a patchwork of data protection laws.

This will change on 25 May 2018 when the EU General Data Protection Regulation (we’ll call this the GDPR from now on) comes into force. This GDPR will replace the Directive. It was initially published in January 2012 and adopted on 27 April 2016. Organisations holding data have only 19 months left to amend their data protection policies, procedures and rules before the Regulation is in force. As it’s a Regulation, it will be immediately applicable across the EU without individual member states having to implement national legislation.

We thought we’d share some of the most important points that relate to you as a patient registry owner and healthcare organisation. We’ve given reference information at the end.

1. The Definition of Personal Data

Under EU law, personal data can only be gathered legally under strict conditions, for a legitimate purpose. In addition, persons or organisations which collect and manage your personal information must protect it from misuse and must respect certain rights of the person which are guaranteed by EU law. This is the fundamental basis of the law.

The definition of personal data has been extended under the GDPR and is more detailed than the previous Directive. It now includes an identification number, location data and online identifier. So if any of those can connect back to a person, it’s included as personal data.

2. Extension of Sensitive Data

The GDPR extends the definition of sensitive data to include “genetic data” and “biometric data”. This is in addition to data relating to racial or ethnic origin, political opinions, religious or philosophical beliefs, trade-union membership, health or sex life.

As with the Directive, sensitive data is afforded more protection and requires more stringent conditions to be satisfied.

3. Anonymised Data

Anonymised data, which is data that doesn’t relate to a person or to personal data rendered anonymous, is not considered to be “personal data” and therefore falls outside the scope of the GDPR.

4. Introduction of the Concept of Pseudonymisation

While we talk about and use the concept of ‘pseudonymisation’, the GDPR introduces it into the Regulation. The GDPR defines it as “the processing of personal data in such a manner that the personal data can no longer be attributed to a specific data subject without the use of additional information, provided that such additional information is kept separately, and is subject to technical [such as encryption] and organisational measures to ensure that the personal data are not attributed to an identified or identifiable natural person” .

That’s the legalese. But in essence, personal data which has undergone pseudonymisation should be considered to be information on an identifiable natural person

However, pseudonymised data will be afforded certain relaxations from the requirements of the GDPR. So for example, where data is pseudonymised and encrypted, a company will not be required to inform the data subject should a breach occur.

5. Strengthened Notion of Consent

The GDPR introduces a higher bar for relying on consent. Like the Directive, the GDPR refers to “consent” and “explicit consent”. The difference between them is vague as both now require some form of clear affirmative action.

The GDPR defines “consent” as “any freely given, specific, informed and unambiguous indication of the data subject’s wishes by which he or she, by a statement or by a clear affirmative action, signifies agreement to the processing of personal data relating to him or her“.

Again, that’s the legalese. But an example of such affirmative action include ticking a box when visiting an internet website rather than having a pre-ticked boxes, silence or inactivity. Those last three will not be sufficient enough to constitute consent.

The GDPR also includes more stringent conditions for information society services (e.g. online businesses) to rely on consent to process children’s data. It requires service providers to verify parental consent to the processing of the child’s data where the child is less than 16 years old. Individual member States may provide by law for a lower age, so long as that age is not below 13 years old.

6. Data controller and data processor

The GDPR also continues with the Directive’s terminology of data controller and data processor, which are used throughout the law.

A data controller is anyone who determines the “purposes and means of processing of the personal data.” It’s another way of saying the controller is the company or organization that makes all the decisions about initially accepting data from the data subject.

A data processor is then anyone who processes data for the controller. The GDPR specifically includes storage as a processing function, so that takes into account, say, cloud-based virtual storage.

The GDPR applies to controllers and processors. It places new legal obligations on processors, with the result that they will be share liability if breaches occur.

7. Operational outside EU

If your health or patient organisation is outside the EU but monitors EU residents, then the new Regulation applies to you too. This is a significant change to the law. The GDPR expands the territorial scope of existing EU data protection laws.

8. Significant Fines

There are new penalties introduced in the GDPR which include fines up to the higher of €20million or 4% of total annual worldwide turnover.

Information Sources

There are good sources of information to learn more about your responsibilities:

If you are a healthcare organisation storing or processing personal data from EU citizens, then we suggest that you look at the European Commission site for more information. http://ec.europa.eu/justice/data-protection/index_en.htm

European Commission – http://ec.europa.eu/justice/data-protection/index_en.htm

A&L Goodbody – http://www.algoodbody.com/EU_General_Data_Protection_Regulation

Filed Under: Data intelligence, Patient Registry

OpenApp Takes Part in Epidermolysis Bullosa/ERN Registry Meeting

June 7, 2016

OpenApp is delighted to take part in an ERN Working Group on Wednesday, 8th June. Representatives from all over Europe will converge in Dublin as part of the proposed ERN for Rare and Undiagnosed Skin Diseases to discuss creating a collaborative patient registry. [Read more…]

Filed Under: Patient Registry, Uncategorized Tagged With: ERN, European Reference Networks

OpenApp Inspire and Inform at Health Conferences

April 7, 2016

Over the past couple of weeks, some of the team here have been attending, exhibiting and speaking at various Health & Rare Disease conferences.

[Read more…]

Filed Under: Patient Registry

OpenApp Supports Rare Disease Day – Making the Voice of Rare Disease Heard

February 2, 2016

2016 marks the ninth year that the international rare disease community celebrates Rare Disease Day. OpenApp is delighted to support this great initiative.

[Read more…]

Filed Under: Patient Registry

Patient Registries in a Digital Europe

December 22, 2015

Rare Disease Patient RegistriesThe PARENT Joint Action recently held its final event entitled ‘Patient Registries in a Digital Europe’. They concluded a successful project which has now provided tools and resources to support the long-term perspective on registry interoperability.

[Read more…]

Filed Under: Patient Registry

  • 1
  • 2
  • Next Page »

In the Media

  • This Dublin tech firm has sealed a €5m deal to help fight rare diseases across Europe
  • OpenApp To Develop Game-Changing Software in The Fight Against Rare Diseases Across Europe
  • Irish company in €5m deal to develop health app
  • Dublin Company Set to Develop Software for Rare Disease Networks
  • OpenApp awarded European Cystic Fibrosis Patient Registry

Events

  • Cambridge International Rare Disease Summit
  • Bringing Solutions to Young Rare Disease Patients
  • 39th European Cystic Fibrosis Conference
  • Rare Disease in Paediatrics – From Birth to Transition
  • Improving Patient Access to Rare Disease Therapies

Popular Posts

  • AeroMedical 5.5.0 released and already in the news
  • AeroMed upgrade released
  • ECFSTracker goes live!
  • OpenApp developed QA programme hailed as major breakthrough
  • Patients urged to seek an appropriate setting

Clinical Insight in Action

  • OpenApp develops European patient registry to support fight against rare disease Tay-Sachs
  • European Cystic Fibrosis Society PR publish Orphanet Journal Article
  • The Rare Disease Puzzle: Bringing the Picture to Life
  • OpenApp awarded European Cystic Fibrosis Patient Registry
  • OpenApp Delighted to Support Rare Disease Day, 28th February 2015

What we’ve done

My Home From Home
HSE - Find a Service
MTCC Suite
NRA Traffic
Emergency Services
HealthAtlas

ICORD

icord

ECRD

ecrd

Clinical Insight in the News

  • OpenApp awarded European Cystic Fibrosis Patient Registry
  • OpenApp developed QA programme hailed as major breakthrough
  • OpenApp attend ECFS 2014, Gothenburg
  • The Rare Disease Puzzle: Bringing the Picture to Life
  • OpenApp Delighted to Support Rare Disease Day, 28th February 2015

Search this Website

Tweets

Twitter
Openapp
Openapp
@OpenappIreland

Common sense advice from Anne Lawlor of @22Q11_Ireland. #EH2030 twitter.com/eHealthI…

reply retweet favourite
11:40 am · October 24, 2017
Twitter
Openapp
Openapp
@OpenappIreland

Looks great @Tay_Sachs. Hope you had a good day #CRDN2017 twitter.com/Tay_Sach…

reply retweet favourite
11:37 am · October 24, 2017
Twitter
Openapp
Openapp
@OpenappIreland

@ataxiaandme @Tay_Sachs @camraredisease @pharmaphorum Looks great. Delighted and honoured to be included.

reply retweet favourite
11:33 am · October 24, 2017
Twitter
Ataxia and Me
Ataxia and Me
@ataxiaandme

@Tay_Sachs @OpenappIreland Slide @camraredisease #CRDN2017 cc @pharmaphorum pic.twitter.com/Os9R…

reply retweet favourite
11:32 am · October 24, 2017 ·
Retweeted by Openapp
Twitter
Openapp
Openapp
@OpenappIreland

As @MetEireann issues a red warning in advance of #ophelia, employees are not expected in 2moro. Back up plan for service desk will operate.

reply retweet favourite
9:43 pm · October 15, 2017
Twitter
Openapp
Openapp
@OpenappIreland

Leading positive changes in our healthcare will be new models of care empowered by patients and enabled by technology. #betterdata4health pic.twitter.com/7we8…

reply retweet favourite
8:46 am · October 4, 2017
Twitter
Openapp
Openapp
@OpenappIreland

Delighted to be here at #betterdata4health. Looking forward to a great morning. pic.twitter.com/kNw4…

reply retweet favourite
8:44 am · October 4, 2017
Twitter
Openapp
Openapp
@OpenappIreland

Our MD @ConHennessy is at @eurodis today. Feel free to say hello.

reply retweet favourite
10:57 am · September 26, 2017
Twitter
Openapp
Openapp
@OpenappIreland

Delighted to be here at @eurordis. twitter.com/RareDise…

reply retweet favourite
10:46 am · September 26, 2017
Twitter
Sean Ring
Sean Ring
@SRingBos

#ERN exists so the knowledge travels and the patient doesn't have to @eurordis #RareDisease

reply retweet favourite
10:40 am · September 26, 2017 ·
Retweeted by Openapp
Follow @OpenappIreland

Contact

P: +353 1 872 9331
E: info@openapp.ie
A: Avoca House, 189-193 Parnell St,
Dublin 1, Ireland
VAT : 6375595I
Registration : 355595
Eircode : D01 H578